ETHZilla to Tokenize $4.7M Manufactured-Home Loan Pool, Targeting ~10.36% Yield
- ETHZilla subsidiary bought 95 manufactured/modular home loans and first‑lien mortgages for about $4.7M.
- ETHZilla will tokenize the portfolio on Ethereum Layer‑2 and launch via Liquidity.io for fractional cash‑flow access.
- ETHZilla pursues cross‑asset tokenization, acquiring aircraft engines and buying 15% of Zippy to strengthen servicing.
On-chain Manufactured Home Loan Offering
ETHZilla Corporation announces that its newly formed wholly owned subsidiary, ETHZilla Modular Mortgage LLC, has acquired 95 manufactured and modular home loans and the first-lien mortgages securing them from Zippy Manufactured Home Credit Fund I L.P. for about $4.7 million. The loans remain serviced by Zippy Loans LLC and represent a seasoned, recurring cash-flow residential credit pool that ETHZilla says is expected to generate an annualized yield of roughly 10.36% from contractual interest payments. The acquisition is the company’s latest move to assemble income-oriented asset pools for digital securitization.
The company plans to tokenize the portfolio as a cash-flow-generating manufactured home loan token using Ethereum Layer 2 infrastructure to enable on-chain asset tracking and automated cash-flow distribution. ETHZilla intends to launch the token through the Liquidity.io ecosystem in late February or early March, positioning the offering to provide fractionalized access to an income stream traditionally limited to specialist investors. The structure aims to combine blockchain transparency and programmable payments with the servicing continuity provided by Zippy Loans.
Executives frame the deal as part of a repeatable tokenization framework for real-world assets that targets institutional-grade infrastructure and regulated, transparent structures. McAndrew Rudisill, ETHZilla’s chairman and CEO, describes the acquisition as a natural extension of the company’s disciplined approach to bringing established, cash-flow-generating assets on-chain. By using an affiliate to hold the loans while retaining an experienced servicer, ETHZilla seeks to mitigate operational risk while demonstrating a model it can apply across different asset classes.
Cross-asset Tokenization Drive
The manufactured home loan deal follows ETHZilla’s recent acquisition of two CFM56-7B24 aircraft engines on lease with a major air carrier, assets the company also intends to tokenize and list on Liquidity.io, underscoring a cross-asset strategy to broaden access to differentiated, income-oriented markets through digitization.
Partnership and Deal Mechanics
The transaction builds on ETHZilla’s December 2025 purchase of roughly 15% of Zippy, Inc., the fund’s parent, which the company says strengthens access to origination, servicing and asset-level expertise in manufactured housing finance and supports the operational foundation for its on-chain offerings.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…